Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Deloitte
UBS
Federal Trade Commission
Teva

Generated: May 23, 2019

DrugPatentWatch Database Preview

Litigation Details for Abbott Laboratories v. Teva Pharmaceuticals (D. Del. )

« Back to Dashboard

Small Molecule Drugs cited in Abbott Laboratories v. Teva Pharmaceuticals
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Abbott Laboratories v. Teva Pharmaceuticals (D. Del. )

Date Filed Document No. Description Snippet Link To Document
2008-09-30 665 by a process taught in U.S. Patent No. 4,800,079 to Boyer. (/d.) This patent generally describes a fenofibrate…compared to the dissolution profile of U.S. Patent No. 4,800,079 to Boyer.”17 (ld. at TiJA-2070) i\/lr. Reginault…with the ‘881 patent or statements made in furtherance of the patentability of the ‘881 patent; there is …of the ‘726 patent (as an inventor), an “audit” of patents in 2001, and discussed patents with PharmaPass…(Teva)3 and lmpax infringe U.S. Patent No. 4,895,726 (“the ‘726 patent”); and (2) in this court, alleging External link to document
2008-10-02 673 by a process taught in U.S. Patent No. 4,800,079 to Boyer. (ld.) This patent generally describes a fenofibrate…compared to the dissolution profile of U.S. Patent No. 4,800,079 to Boyer.”17 (ld. at TlJA-2070) Mr. Reginault…with the ‘881 patent or statements made in furtherance of the patentability of the ‘881 patent; there is …of the ‘726 patent (as an inventor), an “audit” of patents in 2001, and discussed patents with PharmaPass…(Teva)3 and lmpax infringe U.S. Patent No. 4,895,726 (“the ‘726 patent”); and (2) in this court, alleging External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKesson
McKinsey
AstraZeneca
Accenture
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.